(Q30656754)

English

Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Shahneen K Sandhu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Gerald J Fetterly

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Urvi Aras

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Patricia D Meholick

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Chris Takimoto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Shobha Seetharam

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Thomas McIntosh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Johann S de Bono

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Anthony Tolcher

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Hugh M Davis

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Honghui Zhou

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Thomas A Puchalski

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

23 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

53

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1020-1027

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

The human homolog of the JE gene encodes a monocyte secretory protein

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Properties of a general PK/PD model of antibody-ligand interactions for therapeutic antibodies that bind to soluble endogenous targets

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.140

21 January 2018

Identifiers

10.1002/JCPH.140

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23878055%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30656754&oldid=1765243594"